Presentation is loading. Please wait.

Presentation is loading. Please wait.

CLINICAL GOVERNANCE LEADS MEETING

Similar presentations


Presentation on theme: "CLINICAL GOVERNANCE LEADS MEETING"— Presentation transcript:

1 CLINICAL GOVERNANCE LEADS MEETING
DECEMBER 2007 QOF

2 QOF Profiling Reviews All Practices profiled during July on 2006/7 data Qmas, qof, prevalence, exceptions, apollo, admissions, referals, prescribing Practices asked to respond to questions raised by the profiling +/- arranged visit

3 QOF Profiling Review Outcome 2007/8
11 QOF Review Visits 6 former Bedford 5 former Heartlands 7 Informal Practice Visits 3 former Bedford 4 former Heartlands

4 QOF Profiling: submission evidence
To ensure a consistent approach: all practices were asked to submit 2 examples of a Mental Health, Cancer and Dementia annual review. (unless already validated from visits etc)

5 Results What % of submitted reviews met the Brown Book Standards?
Mental Health Reviews - 53% Cancer - 61% Dementia - 45%

6

7 Some issues raised Prevalence Exception codes
Coding issues +/- IT issues Not providing enough data to evidence a claim

8 Low Prevalence? Practice audits discovered following reasons for low prevalence:- Demographics Read Code not used or not recognised by QMAS Patients with the disease but not on the register CKD ! Event type needs to be first ever or new event – particularly for Cancer, Depressions, CHD (for MIs), CKD and Stroke

9 Exceptions EMIS Templates designed in such a way that exceptions codes (particularly Maximum Tolerated) can be easily entered without clinician realising exception code has been added to the record Isoft Template error excepting patients for stroke/AF

10 Exceptions Use of max tolerated codes, especially epilepsy and hypertension Use of blanket computer searches to identify and except people Remember – each exception MUST be an individual judgement with regards to that patient Remember – to explain in the clinical record why you have applied that exception to that patient

11 Exceptions Use of patient unsuitable instead of informed dissent
Coding at incorrect level – excepting at high level rather than individual indicators Remember – each exception MUST be an individual judgement with regards to that patient Remember – to explain in the clinical record why you have applied that exception to that patient

12 New Queries/Clarification
QOF queries New Queries/Clarification

13 QOF Queries ‘New’ codes for Dementia annual review and MH dna – you may need to amend codes you have already applied Depression 1 – the two question must be asked face to face (not validated when asked by letter). Remove any codes added in response to letter Depression 2 - check your prevalence - should be 7-10% ish, Episode type for Cancer, Depression, CHD (MIs) CKD and Stroke

14 Medicines 11 & 12 Brown Book 06/07 different guidance to Blue Book 04/05 Brown Book states …

15 Medication Reviews Med 11 & 12
All patients should have the chance to raise questions and highlight problems about their medicines Medication review improve or optimises impact of treatment on pt Review undertaken in systematic way by a competent person Any changes resulting from review are agreed with patients Review documented in patient notes Impact of changes monitored

16 Medication Reviews Med 11 & 12
All patients should have the chance to raise questions and highlight problems about their medicines Medication review improve or optimises impact of treatment on pt Review undertaken in systematic way by a competent person Any changes resulting from review are agreed with patients Review documented in patient notes Impact of changes monitored


Download ppt "CLINICAL GOVERNANCE LEADS MEETING"

Similar presentations


Ads by Google